After 60 Years, Science Uncovers Metformin’s Hidden Pathway
One of the most common drugs used for type 2 diabetes, metformin, has made headlines across medical articles on March 25 and 26. Researchers at Baylor College of Medicine have said that the medicine not only works through the liver and gut, but it also works through the brain, via a pathway tied to blood sugar control. Something they weren’t aware of since the start of the medication’s use.
In a ScienceDaily report, the newly identified pathway involves a protein called Rap1 in the ventromedial hypothalamus, a part of the brain that helps regulate energy use and glucose.
When researchers removed that protein in mice, low doses of metformin no longer lowered blood sugar the way they normally would.
In the research, the drug activated SF1 neurons in that same area, which gives scientists a more precise map of what has been happening behind the scenes when patients take metformin.
Personal interest and scale of use
As someone who is prescribed metformin and who reads a lot about medical problems, this story both surprises and shocks me.
On the one hand, medications and treatments are often given out without fully knowing how they work. For instance, science didn’t understand how general anesthesia worked and is only now starting to get a fuller picture.
On the other hand, when you look at how many people take metformin, how many actually knew the gaps in how it worked? I didn’t, and neither did science, fully.
When you consider how many people take this medication daily, this revelation about how the medication works will impact some 20.4 million patients nationwide. In a single year, it’s estimated that around 85.7 million prescriptions are made for metformin.
What is metformin and why is it prescribed?
Metformin is an oral drug used to help lower blood sugar in people with type 2 diabetes. The Mayo Clinic notes that it is often the first medicine prescribed for the condition, and FDA labeling says it is used alongside diet and exercise to improve blood sugar control.
It has long been valued because it helps the body use insulin better and reduces glucose production, without the same weight gain or low blood sugar risk seen with some older treatments.
Metformin is not new, and its backstory goes back to 1957. PubMed’s historical overview says its roots trace to Galega officinalis, also called goat’s rue or French lilac, a plant used in Europe for diabetes-like symptoms. The review notes that French physician Jean Sterne first reported metformin’s use for diabetes in 1957, while U.S. approval came decades later, in the mid-1990s.
Past beliefs and what’s next
Baylor’s research team highlighted that metformin was widely believed to work mainly by lowering glucose output in the liver, while other studies pointed to the gut.
The brain angle was harder to pin down, partly because the brain appears to respond at much lower concentrations of the drug, and proving that required genetically engineered mice, direct brain delivery, and neuron-level testing.
There is also an important reality check here. This research was done in mice, not people, so it does not mean doctors are suddenly rewriting diabetes care tomorrow.
A ScienceAlert report on the topic stated that human studies still need to confirm the same pathway in the brain exists. Yet this discovery matters because it may give scientists a clearer picture of why metformin works so well and may even help lead to more targeted diabetes treatments in the future.
More About:Health